Test AltBib.Com Backup Copy Report Broken Link and Get Redirected To Backup Copy
In a number of big ways, the offline backup
is far inferior to this online version,
but it is there juuust in case we lose
free speech as we know it on the internet.
DATABASE TOTALS:6,082 Reference Links,
with 11,639 Tags/Keywords,
with 68,035 Taggings
AltBib.Com is a free, research database with articles,
documents and videos shining light on interesting topics.
Most links are to significant information 'validated' as 'true' by the Mainstream Media, sometimes buried in the final paragraphs,
which are directly referenced by the Alternative Media/New Media in creating controversial alternative analysis.
So check out some mainstream evidence and see if you naturally end up agreeing with an alternate analysis.
You can pick a tag/keyword/topic or source from the menus above to start wandering the database,
or make more complicated Custom Filters.
Or use the Search bar to type in tags or news headlines to refine your filter.
Please help this resource grow by suggesting new links, and adding tags to or rating links.
More tools launching soon...
Documents are largely from what is referenced by interesting films, Prison Planet/Infowars and the Corbett Report. This database is a quick reference and for your analysis, more independent from others' interpretations. The database includes almost all source documents and articles from these films: Loose Change (Final Cut & 2nd Edition), Fabled Enemies, The Obama Deception, End Game, Martial Law 9/11, American Dictators, Matrix of Evil, Zeitgeist: Addendum, Who Killed The Electric Car?, The World According To Monsanto, Mind The Gap, and 7/7 Ripple Effect.
It's a swine mess: Government set to force OAPs to have pig vaccine with flu jab MILLIONS of people will be given a secret swine flu jab by health bosses this winter.
The H1N1 vaccine will be mixed into the regular flu jab for OAPs, pregnant women and others at high risk.
While millions refused to take the jab during last winter's pandemic, this time they will have no choice if they want to be protected against normal flu.
The Government was left with more than 30million swine flu vaccines after the pandemic fizzled out in 2010. (New of the World)
Dutch government wants to sell flu vaccines back The Dutch government wants to sell 21 million unused H1N1 flu vaccine doses back to their manufacturers after they proved unnecessary and no other country wanted to buy them, the Health Ministry said on Saturday. (Reuters)
H1N1 swine flu hoax falls apart at the seams The great swine flu hoax of 2009 is now falling apart at the seams as one country after another unloads hundreds of millions of doses of unused swine flu vaccines. No informed person wants the injection anymore, and the entire fear-based campaign to promote the vaccines has now been exposed as outright quackery and propaganda.
Even doctors are now calling the pandemic a complete hoax. As reported on FoxNews, Dr. Wolfgang Wodarg, a leading health authority in Europe, says that drug companies "organized a 'campaign of panic' to put pressure on the World Health Organization (WHO) to declare a pandemic. He believes it is 'one of the greatest medicine scandals of the century,' and he has called for an inquiry." (Natural News)
GlaxoSmithKline (GSK.L) shipped swine flu vaccine worth 835 million pounds ($1.36 billion) to governments in the last quarter of 2009 but the drugmaker said on Friday it was too early to say what the final total would be.
The quarterly total is less than the 1 billion pounds or so that many analysts had been forecasting.
The British company, which is the biggest supplier of H1N1 vaccines, has been hit in recent weeks by a series of order cancellations following slow uptake of the shots.
Belgium became the latest country to cut its order, cancelling a third of the supply originally booked from Glaxo earlier on Friday, in line with a similar reduction by Germany. (Reuters)
ČR does not want Baxter's swine flu vaccine without licence Deputy Health minister Marek Snajdr told CTK yesterday that the Czech Republic will not buy swine flu vaccine from Baxter company before it has European registration. He said the vaccine may have side effects and it may even cause death if used. (Prague Daily Monitor)
Greece to vaccinate population for swine flu Greece will vaccinate its entire population of 12 million against the H1N1 swine flu pandemic which has swept around the world in weeks, killing hundreds of people, the country's health minister said on Friday (TV NZ)
A/H1N1 vaccination plan a big experiment, doctor says The enormous vaccination programme against the A/H1N1 swine flu virus due to start this autumn across Germany is nothing less than a huge experiment, a prominent critic of the pharmaceutical industry says (The Local)
U.S. has bought 195 million doses of H1N1 vaccine The U.S. Health and Human Services Department has also contracted for 120 million doses of adjuvant, a compound to stretch the number of doses of vaccine needed, the department's Dr. Robin Robinson told a meeting of Food and Drug Administration advisers (Reuters)
Drug groups to reap swine-flu billions Analysts expect to see a boost in sales from GlaxoSmithKline, Roche and Sanofi-Aventis when the companies report first-half earnings lifted by government contracts for flu vaccines and antiviral medicines (Financial Times)
Battery grade, natural; battery grade, synthetic; chemical grade; ferro; metallurgical grade Guinea: Bauxite (Mine) South Africa: BAE Land System OMC, Benoni, South Africa Brown David Gear Industries LTD, Benoni, South Africa Bushveld Complex (chromite mine) Ferrochromium Manganese
Battery grade, natural; battery grade, synthetic; chemical grade; ferro; metallurgical grade Palladium Mine and Plant Platinum Mines Rhodium EAST ASIA AND THE PACIFIC Australia: Southern Cross undersea cable landing, Brookvale, Australia Southern Cross undersea cable landing, Sydney, Australia Manganese
Battery grade, natural; battery grade, synthetic; chemical grade; ferro; metallurgical grade Nickel Mines Maybe Faulding Mulgrave Victoria, Australia: Manufacturing facility for Midazolam injection. Mayne Pharma (fill/finish), Melbourne, Australia: Sole suppliers of Crotalid Polyvalent Antivenin (CroFab). China: C2C Cable Network undersea cable landing, Chom Hom Kok, Hong Kong C2C Cable Network undersea cable landing Shanghai, China China-US undersea cable landing, Chongming, China China-US undersea cable landing Shantou, China EAC undersea cable landing Tseung Kwan O, Hong Kong FLAG/REACH North Asia Loop undersea cable landing Tong Fuk, Hong Kong Hydroelectric Dam Turbines and Generators Fluorspar (Mine) Germanium Mine Graphite Mine Rare Earth Minerals/Elements Tin Mine and Plant Tungsten
Mine and Plant Polypropylene Filter Material for N-95 Masks Shanghai Port Guangzhou Port Hong Kong Port Ningbo Port Tianjin Port .... (US Department of State)
Washington's largest lobby, the pharmaceutical industry, racked up another banner year on Capitol Hill in 2007, backed by a record $168 million lobbying effort, according to a Center for Public Integrity analysis of federal lobbying data (Center for Public Integrity)
Rumsfeld Profits From Bird Flu Scare Among the beneficiaries of the run on Tamiflu is Secretary of Defense Donald Rumsfeld, who was chairman of Gilead from 1997 to 2001 and owns at least $5 million of the stock, which has jumped from $35 in April to $47. Former Secretary of State George Shultz, who is on Gilead's board, has sold more than $7 million worth of Gilead in 2005 (Fortune)
More Bitter Pills For Big Pharma: Patents are expiring on blockbuster drugs, and there's not much in the pipelines -- Executives fear that Washington will get tough in the wake of the Vioxx debacle Last year, Merck & Co. made pharmaceutical history as the company that suffered the greatest agony due to a pain remedy. In September, Merck withdrew Vioxx, its $2.5 billion pain medication, after a study confirmed fears that the drug raised the risk of heart attacks.
Within weeks, Merck had plenty of company: A study linked Pfizer Inc.'s (PFE ) Celebrex to heart problems. Eli Lilly & Co. (LLY ) warned of potential liver problems with Strattera, a drug for attention-deficit hyperactivity disorder. AstraZeneca PLC (AZN ) disclosed that Iressa, a lung cancer treatment, did not extend patients' lives. And Crestor, a cholesterol-lowering drug from the same company, fell under scrutiny for potential side effects. By the end of the year, all this heat was battering pharmaceutical company valuations and misting future prospects for drug stocks.
The current year is unlikely to mark a return of robust health for the drug sector. A preliminary estimate from business information and consulting firm IMS Health (RX ) shows drug sales in the U.S. will be up 9.5% this year, to $259 billion. That's a tad better than 2004, with estimates showing sales rising 9%. But it's hardly a stellar performance: The industry hadn't posted single-digit growth since 1994. (Bloomberg)
The Truth About the Drug Companies Every day Americans are subjected to a barrage of advertising by the pharmaceutical industry. Mixed in with the pitches for a particular drug—usually featuring beautiful people enjoying themselves in the great outdoors—is a more general message. Boiled down to its essentials, it is this: “Yes, prescription drugs are expensive, but that shows how valuable they are. Besides, our research and development costs are enormous, and we need to cover them somehow. As ‘research-based’ companies, we turn out a steady stream of innovative medicines that lengthen life, enhance its quality, and avert more expensive medical care. You are the beneficiaries of this ongoing achievement of the American free enterprise system, so be grateful, quit whining, and pay up.” More prosaically, what the industry is saying is that you get what you pay for.
Is any of this true? Well, the first part certainly is. Prescription drug costs are indeed high—and rising fast. Americans now spend a staggering $200 billion a year on prescription drugs, and that figure is growing at a rate of about 12 percent a year (down from a high of 18 percent in 1999).1 Drugs are the fastest-growing part of the health care bill—which itself is rising at an alarming rate. The increase in drug spending reflects, in almost equal parts, the facts that people are taking a lot more drugs than they used to, that those drugs are more likely to be expensive new ones instead of older, cheaper ones, and that the prices of the most heavily prescribed drugs are routinely jacked up, sometimes several times a year.
Before its patent ran out, for example, the price of Schering-Plough’s top-selling allergy pill, Claritin, was raised thirteen times over five years, for a cumulative increase of more than 50 percent—over four times the rate of general inflation.2 As a spokeswoman for one company explained, “Price increases are not uncommon in the industry and this allows us to be able to invest in R&D.”3 In 2002, the average price of the fifty drugs most used by senior citizens was nearly $1,500 for a year’s supply. (Pricing varies greatly, but this refers to what the companies call the average wholesale price, which is usually pretty close to what an individual without insurance pays at the pharmacy.)
This is an industry that in some ways is like the Wizard of Oz—still full of bluster but now being exposed as something far different from its image. Instead of being an engine of innovation, it is a vast marketing machine. Instead of being a free market success story, it lives off government-funded research and monopoly rights. Yet this industry occupies an essential role in the American health care system, and it performs a valuable function, if not in discovering important new drugs at least in developing them and bringing them to market. But big pharma is extravagantly rewarded for its relatively modest functions. We get nowhere near our money’s worth. The United States can no longer afford it in its present form. (The New York Review of Books)
This database has been loaded 1,793,399 times since May 2009.
FAIR USE NOTICE:
This site contains copyrighted material the use of which has not always been specifically
authorized by the copyright owner. We are making such material available in our efforts to advance
understanding of criminal justice, political, human rights, economic, democracy, scientific, and
social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material
as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107,
the material on this site is distributed without profit to those who have expressed a prior interest in
receiving the included information for research and educational purposes. For more information go to:
http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own
that go beyond 'fair use', you must obtain permission from the copyright owner.
Watch Interesting Films:
Corbett Report Podcasts:
Interesting 
Not Interesting 
Add Another Tag/Keyword To Link
Test AltBib.Com Backup Copy
Report Broken Link and 
AltBib.Com is a free, research database with articles,
documents and videos shining light on interesting topics.
Most links are to significant information 'validated' as 'true' by the Mainstream Media, sometimes buried in the final paragraphs,
which are directly referenced by the Alternative Media/New Media in creating controversial alternative analysis.
So check out some mainstream evidence and see if you naturally end up agreeing with an alternate analysis.
Glaxosmithkline
Top Tags: 100 Keywords
Top Tags: 100 Groups
Top Tags: 100 People
Top Tags: 100 Locations
Most Recently Posted Links
Facebook Recommendations & Activity
Customize From Full List
United States 
Terrorists 
9/11 
George W Bush 
Barack Obama 
US Congress 
United Kingdom 
Central Intelligence Agency 
Federal Bureau Of Investigation 
Privacy 
Al-qaeda 
Military 
Police 
Financial Crisis 
White House 
Osama Bin Laden 
Iraq 
Internet 
Canada 
Climate Change 
Afghanistan 
Pentagon 
United Nations 
China 
European Union 
Wikipedia 
New York Times 
BBC 
CNN 
Associated Press 
Washington Post 
London Guardian 
London Telegraph 
Reuters 
The Raw Story 
FOX 
UK Daily Mail 
Bloomberg 
London Times 
CBS 
Prison Planet 
ABC 
Wall Street Journal 
Huffington Post 
Agence France-Presse 
MSNBC 
World Net Daily 
CSPAN 
The Register 
CBC 
Suggest Document Link
Web Site Feedback
Search: 
:
